Securities code: Lens Technology Co.Ltd(300433) securities abbreviation: Lens Technology Co.Ltd(300433) Announcement No.: pro 2022015 Lens Technology Co.Ltd(300433)
Announcement on risks affected by the epidemic
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Due to the continuous development of New Coronavirus epidemic in China recently, Lens Technology Co.Ltd(300433) has been affected to varying degrees. The company has taken a series of measures to actively respond, and the specific impact of the epidemic on the company’s operating performance cannot be predicted. The relevant information is disclosed as follows:
1、 Specific situation of the epidemic and its impact on the company
(I) Lens Technology Co.Ltd(300433) (Dongguan) Co., Ltd
The company’s wholly owned subsidiary, Lens Technology Co.Ltd(300433) (Dongguan) Co., Ltd. (hereinafter referred to as “Dongguan blue”) has been required to carry out epidemic prevention and control in accordance with the Circular of the office of New Coronavirus disease prevention and control headquarters of Songshan Lake, Dongguan. It has arranged staff separation and nucleic acid detection, and has suspended production activities to fully cooperate with the government’s epidemic prevention work to curb the spread and spread of the epidemic. The time for Dongguan Lansi to resume normal production and operation is uncertain, and corresponding arrangements will be made according to the requirements of the local government for epidemic control.
The operating revenue of Dongguan Lansi in the first three quarters of 2021 accounted for 6.76% of the company’s total operating revenue (Unaudited). The shutdown will have an impact on the production and delivery of products and the research and development of new products of some customers. The specific impact degree is subject to the audited financial report of 2022.
(II) Logistics Impact
Affected by the continuous development of the epidemic outside China, the company encountered some difficulties in cross-border logistics of some raw and auxiliary materials, chips and other materials purchased from abroad, which had a certain impact on the company’s main business. At the same time, the Vietnam epidemic has also had a certain impact on the cross-border logistics link of the company’s product delivery.
To sum up, the company’s cross-border procurement costs, labor costs and comprehensive delivery costs are adversely affected. The company has taken measures to coordinate resources to ensure that the procurement and delivery related to the company’s production and operation are met in time as far as possible. 2、 Countermeasures
In order to minimize negative impacts, control risks and effectively protect the interests of all shareholders, the company will take the following countermeasures:
1. Dongguan Lansi strictly implemented the epidemic prevention and control measures in accordance with the government’s epidemic prevention and control requirements, actively cooperated with relevant departments to carry out flow investigation and prevent the risk of epidemic spread;
2. The company actively communicates with customers, optimizes production capacity arrangement and strives to achieve product delivery;
3. On the premise of strictly complying with the requirements of epidemic prevention and control, Dongguan Lansi made preparations for resumption of work and production in advance, and strive to resume normal production and operation as soon as possible and reduce losses;
4. Strengthen communication with the government, continue to actively coordinate cross-border logistics resources, enable alternative transportation capacity and schemes, and minimize the impact of logistics obstruction;
5. All parks and subsidiaries of the company further do a good job in epidemic prevention and control, and appropriately reserve epidemic prevention materials and production materials in advance.
3、 Risk tips
The epidemic will not have an adverse impact on the company’s long-term development, and the specific impact on the company in the short term can not be predicted. The company will pay close attention to the development of the epidemic and timely perform the obligation of information disclosure in accordance with relevant regulations. Please pay attention to the investment risks of investors.
It is hereby announced.
Lens Technology Co.Ltd(300433) board of directors March 15, 2002
